Harnessing Menstrual Fluid for Advanced Diagnostic Techniques

Hey folks, For most of history, menstrual blood has been treated as something to hide and never as data. With NextGen Jane’s tampon-based multi-omics approach, menstrual fluid is now becoming a valuable diagnostic resource. Stephen Gire, CSO at NGJ, said in an article. “With molecular tools, physicians could potentially diagnose and treat earlier, drug developers could find new targets, leading to more-refined therapeutics, and run more-efficient clinical trials.” Read more. We are excited to have him join our experts for our upcoming webinar, Building a Predictive Diagnostic Model from Menstrual Fluid Data. We will break down new insights and practical ways to work with a sample type that has hardly been studied before. Learn how to turn scattered clinical notes, symptom histories, and EMR data into a unified picture alongside menstrual‑omics and see a concrete framework for connecting longitudinal patient records to new datasets so your predictive models are reliable enough, straight from the experts who have already done it. Date - December 2nd, 2025 Time - 9 AM PT Register Now to Join Menstrual fluid is one of the richest and untapped biological samples in modern medicine. It carries genomic, transcriptomic, proteomic, and immune signatures that can reshape how we diagnose conditions earlier and more accurately. Your insights, skepticism, and questions can enrich a conversation that has been absent from mainstream biomedical research. If relevant, please circulate it within your network.